Blood-pressure lowering significantly reduces cardiovascular risk in patients with chronic kidney disease.

[Comment] Cardiovascular benefit of blood-pressure lowering in chronic kidney disease www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00553-2/fulltext?rss=yes Chronic kidney disease (CKD) has long remained at the margins of the evidence base for the cardiovascular benefits of blood-pressure lowering. The absolute risk of cardiovascular events in people with CKD is among the highest across major clinical…

[Articles] Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00367-3/fulltext?rss=yes In the context of cardiovascular risk reduction, the relative benefit of blood-pressure lowering in patients with CKD is similar to that in individuals without CKD, with consistent efficacy across all CKD stages, blood-pressure thresholds, and proteinuria…